Abstract
OBJECTIVE: To observe the clinical efficacy of puerarin in treating patients with unstable angina (UA). METHODS: Frequency of angina events, consumed doses of nitrates, heart rate, blood pressure, rest electrocardiogram (ECG) and myocardial oxygen consumption were observed before and after drug therapy in puerarin group (21 cases) and control group (18 cases) respectively. RESULTS: The puerarin group not only showed more effective than that in control group in reducing frequency of angina events and consumed doses of nitrates and improving abnormal rest ECG, but also appeared to be preferable to the control group in reducing myocardial oxygen consumption and increasing exercise duration (P < 0.05). CONCLUSION: Puerarin is a safe and effective drug in treating patients with UA.
Cite
CITATION STYLE
Zhao, Z., Yang, X., & Zhang, Y. (1998). Clinical study of puerarin in treatment of patients with unstable angina. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine / Zhongguo Zhong Xi Yi Jie He Xue Hui, Zhongguo Zhong Yi Yan Jiu Yuan Zhu Ban, 18(5), 282–284. https://doi.org/10.1007/bf02935486
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
